Inhibition of IL-1β by canakinumab may be effective against diverse molecular subtypes of lung cancer: an exploratory analysis of the CANTOS trial
published in: Cancer Research
date of publication: 2020-10-06
Cites articles
There is nothing here
Article - wd:Q100463433